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Abstract TlpA, the membrane-anchored, thioredoxin-like pro-
tein from Bradyrhizobium japonicum, is essential for cytochrome 
aa3 biogenesis. The periplasmic domain of TlpA was previously 
shown to have protein thiol: disulfide oxidoreductase activity and 
reducing properties similar to those of cytoplasmic thioredoxins. 
Here, we replaced the proline-109 in its active-site sequence 
cio7Vio8pio9Ciio b y a h l s t l d i n e residue. The resulting active-
site motif (CVHC) resembles that of oxidizing thiol: disulfide 
oxidoreductases such as protein disulfide isomerase (PDI) and 
DsbA. Indeed, the TlpA variant P109H was by 66 mV more 
oxidizing than the wild-type protein. Nevertheless, the altered 
protein was even more efficient in catalyzing the reduction of 
insulin disulfides by dithiothreitol than the wild-type due to a 
faster recycling of its catalytically active, reduced form. Cells of 
B. japonicum expressing only the mutated tip A gene had the 
same phenotypes as wild-type cells, suggesting that the change in 
the redox potential of TlpA was not critical for its in vivo 
function. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The TlpA protein of Bradyrhizobium japonicum, a Gram-
negative soil bacterium able to live in root-nodule symbiosis 
with soybean, belongs to the family of protein thiol: disulfide 
oxidoreductases and has been shown to be essential for cyto-
chrome aa3 maturation [1]. The monomeric 23 kDa protein is 
anchored to the cytoplasmic membrane with its N-terminal 
transmembrane domain (residues 12-35), whereas the hydro-
philic, thioredoxin-like domain (residues 36-221) faces the 
periplasm [1]. The latter domain was purified as a soluble 
protein (TlpAsoi) after cleavage of a MalE-TlpAsoi fusion pro-
tein. Apart from its active-site disulfide bond which is com-
mon to all protein thiol:disulfide oxidoreductases, TlpAsoi 
possesses a second, structural disulfide bond [2]. It was found 
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that reduced glutathione (GSH) selectively reduces the active-
site disulfide bond, which leads to a 10-fold increase of the 
intrinsic tryptophan fluorescence of TlpAsoi. The redox state-
dependent fluorescence of TlpAsoi provides a means to deter-
mine its redox properties. The TipAsoi:glutathione equilibrium 
constant at pH 7.0 was found to be 1.9 M, corresponding to a 
standard redox potential of —0.213 V. This suggests a reduc-
ing function for TlpA in vivo, similar to cytoplasmic thiore-
doxins [3], which is consistent with the observation that 
TlpAsoi is not a substrate of oxidizing periplasmic disulfide 
oxidoreductases such as DsbA [3]. 
TlpA, like thioredoxins, contains the amino acid sequence 
motif CXPC in its active site (Fig. 1). By contrast, bacterial 
DsbA proteins and eukaryotic PDIs contain the motif CXHC. 
These proteins have a higher redox potential which makes 
them ideal oxidants of protein thiols. A mutation of Pro34 
to His in thioredoxin from Escherichia coli changed its redox 
potential to a more positive value [13] and also increased its 
disulfide isomerase activity [14]. Consistent with this finding, 
an exchange of His32 by Pro in E. coli DsbA decreased the 
redox potential of that protein [15]. In this work we mutated 
the active-site residue Pro109 of TlpA to His to possibly gen-
erate an oxidizing variant of TlpA. The mutated tlpA gene 
was introduced into the genome of a B. japonicum tipA~ 
strain to investigate the influence of TlpA's redox potential 
on several phenotypes associated with the function of TlpA in 
B. japonicum. 
2. Materials and methods 
2.1. Bacterial strains and culture conditions 
All bacterial strains used are listed in Table 1. E. coli strains DH5a 
and TGI were used for cloning and propagation of phage M13, re-
spectively. Expression of TlpAsoi for protein purification was per-
formed in strain BL21. Strain SI7-1 served as donor to mobilize 
plasmids into B. japonicum recipients by conjugation. E. coli cells 
were usually grown aerobically in Luria Bertani (LB) medium at 
37°C. For production of TlpA^, E. coli BL21 was grown at 26°C. 
B. japonicum cells were grown aerobically in peptone-salts-yeast ex-
tract (PSY) medium [20] at 28°C. Antibiotics were added at the fol-
lowing final concentrations: ampicillin, 100 (xg/ml; kanamycin, 100 
ug/ml; tetracycline, 15 |Xg/ml for E. coli strains, 60 Hg/ml for B. japo-
nicum strains; chloramphenicol, 10 |xg/ml. 
2.2. Recombinant DNA work 
Plasmid isolation, cloning, transformation, Southern blotting and 
DNA sequencing were performed according to standard protocols 
[22,23], DNA probes for hybridization were labelled with the digoxi-
genin DNA labelling kit from Boehringer (Mannheim, Germany). 
2.3. Site-directed mutagenesis 
The exchange of Pro109 to His in TlpA was created by in vitro 
0014-5793/97/517.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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mutagenesis (version 2 of the system from Amersham, Buckingham-
shire, UK). For this purpose, we used the phage M13mpl8 derivative, 
M13mpl8f//>^-7, carrying the BamHl-Sall fragment from tlpA, and 
the oligonucleotide primer P109H (5'-CCTTCCGACAGTGCACG-
CACCAGG-3'). The introduction of the correct mutation was con-
firmed by sequencing, and the mutated clone was named 
Mttmp\%tlpP109H. 
2.4. Construction of plasmids and B. japonicum mutant strains 
The plasmids used in this work are listed in Table 1. Plasmid 
pRJ3580 was created by isolating the BamHl-Hindlll fragment with 
the tip A mutation from M13mpl8//pP/09// RF-DNA and ligating it 
into plasmid pRJ3548 [2] from which the corresponding BamHI-Hin-
dlll wild-type fragment had been removed. 
For overproduction of the mutant protein, a 620-bp Banl fragment 
encoding the soluble domain of TlpA(P109H) was isolated from 
pRJ3580 and (after filling in the ends) ligated into the vector pMal-
p that had been digested with Stul. The translational malE'-'tlpP109H 
fusion in the resulting plasmid, pRJ3581, was confirmed by sequenc-
ing. 
Plasmid pRJ3556 was constructed to create the tlpA deletion mu-
tant, BJ3556. For this purpose, the 540-bp BamHl-Nrul fragment of 
tlpA was first removed from plasmid pRJ3548 and replaced by the 
1398-bp BamHl-Nrul fragment from plasmid pUC4-KIXX carrying 
the aphll gene for kanamycin resistance. This resulted in plasmid 
pRJ3552 with the aphll gene being transcribed in the same direction 
as tlpA. The construct was then transferred into vector pSUP202pol3 
by isolating the Xbal-Hpal fragment from pRJ3552, filling in the ends 
and ligating it into pSUP202pol3 that had been digested with EcoRl 
and Xhol (ends made blunt by filling in). The resulting plasmid, 
pRJ3556, was mobilized into B. japonicum HOspcA cells, and kana-
mycin-resistant, tetracycline-sensitive clones were selected. The re-
placement of the chromosomal wild-type tip A gene by the tip A:: aphll 
gene due to double crossover was then confirmed by appropriate 
Southern blot analysis. 
Plasmids pRJ3582 and pRJ3583 were obtained by isolating the 
corresponding 1.6-kb Xhol fragments from pRJ3580 and pRJ3548, 
respectively, and ligating them into A7?oI-digested pSUP202pol3. 
Strains BJ3582 and BJ3583 were then created by introducing 
pRJ3582 and pRJ3583, respectively, into the tlpA deletion mutant 
BJ3556 and selecting for kanamycin- and tetracycline-resistant clones. 
The correct co-integration of the plasmids upstream of the tlpA dele-
tion in the B. japonicum chromosome was confirmed by Southern blot 
analysis. 
DTT were examined by the increase of tryptophan fluorescence using 
a SX-17MV Stopped-Flow Reaction Analyser (Applied Photophysics, 
Leatherhead, UK) with an excitation wavelength of 295 nm and an 
emission cut-off filter of 320 nm. The reaction was performed at 25°C 
under pseudo first-order conditions in 0.1 M potassium phosphate 
buffer, pH 7.0, 1 mM EDTA (filtered) with a final protein concen-
tration of 1 uM and final DTT concentrations of 1 mM for wild-type 
TlpAsol and 100 uM for the P109H variant. For calculation of the 
second-order rate constant (K2), the exact concentration of reduced 
DTT was determined as described by Ellman [25]. 
2.9. Determination of the redox potential 
The redox potential of the active-site cysteines of TlpAsoi(P109H) 
was calculated from the equilibrium constant with glutathione at pH 
7.0 and 30°C as described previously for the wild-type protein [3], 
2.10. Enzyme assays 
Cytochrome c oxidase activity was determined from membrane 
preparations of aerobically grown B. japonicum cells. The membrane 
proteins were solubilized by 1% dodecylmaltoside in 50 mM HEPES/ 
NaOH, pH 7.5, and oxidation of reduced cytochrome c (from horse 
heart) was followed at 550 nm essentially as described by Zufferey et 
al. [26]. 
2.11. Plant infection test 
Soybean seedlings (Glycine max L. Merr. cv Williams) were inocu-
lated with the corresponding B. japonicum strains and grown as de-
scribed by Hahn and Hennecke [27]. After 21 days, nitrogen fixation 
activities of the root nodules were determined by the acetylene reduc-
tion assay [28], and the number, size, colour and dry weight of the 
nodules were recorded. With each B. japonicum strain, 8-10 soybean 
plants were tested. 
3. Results 
Previous work from different groups has shown that the 
redox potential of protein thiol:disulfide oxidoreductases is 
influenced by the amino acid residues located between the 
two active-site cysteines [13,15]. To further characterize the 
in vivo function of TlpA from B. japonicum, we substituted 
Pro1 0 9 for His by site-directed mutagenesis of the tip A gene. 
2.5. Purification of TlpAsoi(P109H) 
TlpAsoi(P109H) was expressed as a MalE fusion protein in E. coli 
BL21. After preparing the periplasmic fraction according to Loferer et 
al. [3], the fusion protein was purified by affinity chromatography on 
an amylose column. TlpAsoi(P109H) was then cleaved off by digestion 
with factor Xa and separated from MalE by ion exchange chroma-
tography using a DEAE Sepharose fast-flow column as described 
previously for wild-type TlpA^ [2]. 
2.6. Determination of protein concentration 
The concentration of purified TlpAsoi and TlpAsoj(P109H) was de-
termined by the absorbance at 280 nm and using an extinction coef-
ficient of E280nm = 17,270 M _ 1 cm - 1 for the native, oxidized protein 
[3]. The protein concentration of membrane preparations was meas-
ured by using the Bradford reagent from Bio-Rad Laboratories (Rich-
mond, CA). 
2.7. Insulin disulfide reduction assay 
The TlpAsoi-catalyzed reduction of insulin disulfides by dithiothrei-
tol was analyzed according to the method of Holmgren [24], that was 
slightly modified as follows. TlpAsoi and TlpAsol(P109H) were prein-
cubated with the reaction buffer (0.1 M potassium phosphate buffer, 
pH 7.0, 2 mM EDTA) containing 1 mM DTT at 25°C for 45 min to 
allow reduction of the proteins by DTT. The reaction was then started 
by addition of insulin to a final concentration of 0.13 mM. Thiore-
doxin from E. coli (Promega, Madison, WI) was used as a positive 
control. 
2.8. Kinetics of TlpAxi and TlpAml(P109H) reduction by DTT 
The kinetics of the reduction of TlpA,0i and TlpAsoi(P109H) by 
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Fig. 1. Comparison of the active-site sequences of different members 
of the protein thiol: disulfide oxidoreductase family. The sequences 
of thioredoxin, DsbA and PDI are from the following organisms: 
Brady rhizobium japonicum (Bj), Rhodobacter sphaeroides (Rs), Bacil-
lus subtilis (Bs), Escherichia coli (Ec), Saccharomyces cerevisiae (Sc), 
Homo sapiens (Hs), Haemophilus influenzae (Hi) and Azotobacter 
vinelandii (Av). The two thioredoxin-like domains of PDI are re-
ferred to as (1) and (2). References [1,4-12] are indicated in brackets 
behind the sequences. The sequence of DsbA from A. vinelandii was 
derived from the Swiss Prot data base (accession number L76098). 
The two active-site cysteines and the amino acid residue preceding 
the second cysteine are shown in bold face letters. 
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The soluble domain (residues 36-221) of the TlpA(P109H) 
variant was expressed in E. coli and purified, yielding 4 mg 
pure protein from a 2-1 culture. Wild-type TlpAso] was also 
purified with the same yield. The fluorescent properties of 
oxidized and dithiothreitol-reduced TlpAsoi(P109H) were sim-
ilar to those of the wild-type protein [3]. The increase of the 
intrinsic tryptophan fluorescence upon reduction of the active-
site disulfide was used to determine the TlpAsoi(P109H):glu-
tathione equilibrium constant at pH 7.0 and 30°C. For this 
purpose, oxidized TlpAsoi(P109H) was incubated in the pres-
ence of 20 uM GSSG and varying concentrations of GSH 
(0.01-10 mM), corresponding to [GSH]2/[GSSG] ratios of 
5 uM to 1.4 M. Fig. 2 shows the fraction of reduced 
TlpAsoi(P109H) at equilibrium (R) that was calculated from 
the measured fluorescence (F) according to Eq. 1, where FTe^ 
and ,F0X are the fluorescence intensities of completely reduced 
and oxidized protein, respectively. 
R = (F—Fox)/(Fma—Fox) (1) 
The redox equilibrium of TlpAsoi(P109H) with glutathione is 
described by Eq. 2-5. 
K,. 
TlpAred + GSSG ^ TlpAox + 2 GSH 
Kn, 
R 
_ [TlpAox] X [GSH]
2 
[TlpAred] X [GSSG] 
([GSH]2/[GSSG]) 
' Keq + ([GSH]
2/[GSSG]) 
(2) 
(3) 
(4) 
[GSH]2/[GSSG] (M) 
Fig. 2. Redox equilibrium of TlpAsoi(P109H) and TlpAsoi with glu-
tathione. Proteins (1 |xM) were incubated at 30°C in 100 mM so-
dium phosphate buffer, pH 7.0, containing 1 mM EDTA and gluta-
thione as follows: 20 uM GSSG and 0.01-10 mM GSH for 
TlpAsol(P109H) (■) and 10 uM GSSG and 0.25-125 mM GSH for 
TlpAsol (•). After 20 h, the fraction of reduced protein (R) at equi-
librium was measured using the specific fluorescence of the proteins 
at 355 nm (excitation at 295 nm). The data were fitted according to 
Eq. 4 (see text). 
Table 1 
Strains, phages and plasmids 
Stram/phage/plasmid Relevant characteristics Reference/source 
E. coli strains 
DH5a 
TGI 
S17-1 
BL21 
B. japonicum strains 
UOspcA 
BJ3556 
BJ3582 
BJ3583 
Phages 
M13mpl8 
M13mpl8//p7 
MUmp\MpP109H 
Plasmids 
pUC18 
pRJ3548 
pRJ3580 
pMal-p 
pRJ3581 
pUC4-KIXX 
pRJ3552 
pSUP202 
pSUP202pol3 
pRJ3556 
pRJ3582 
pRJ3583 
supEAA AlacU169 (<D80/acZAM 15) hsdRll recAl endAl relAl 
K12, A(lac, pro) supE thi hsdA5, F'(traB36 proA+B+ lacF lacZAMXS) 
pro thi hsdR, RP4-2 kan::Tn5 tet::Mu, integrated in the chromosome 
F~ ompT rB~ rriB~ 
Spr (wild type) 
AtlpA, Km' 
BJ3556, plasmid pRJ3582 (tlpP109H+) co-integrated in the chromosome 5' of AtlpA 
BJ3556, plasmid pRJ3583 (tlpA+) co-integrated in the chromosome 5' of AtlpA 
520-bp BamYil-Sall fragment of tlpA in M13mpl8 
M13mpl8?/p7, codon 109 of tlpA (CCC for Pro) mutated to CAC (for His) 
Apr 
Apr, 3.2-kb £coRI fragment (tlpA+) in pUC18 (250-bp Smal-Ndel fragment removed) 
335-bp ftwiHI-ffircdlll fragment of pRJ3548 replaced by the BamHl-Hindlll fragment 
from MnmpmipP109H 
Apr, lacIPtBCmalE-fx-lacZa 
620-bp Banl fragment of pRJ3580 cloned into the Stul site of pMal-p 
Apr, Km', lacZ::aphII 
540-bp BamHl-Nrul fragment of pRJ3548 {tlpP109H+) replaced by the 1.4-bp aphll 
cassette (Km') of pUC4-KIXX 
Apr, Cm', Tcr, oriT from RP4 
Tc1, Drall-EcoRl part of the pBluescript II KS+polylinker between EcoRI and Pstl 
ofpSUP202 
2.06-kb Xbal-Hpal fragment from pRJ3552 {AtlpA::aphll) cloned into pSUP202pol3 
1.6-kb Xhol fragment from pRJ3580 (tlpP109H+) cloned into pSUP202pol3 
1.6-kb Xhol fragment from pRJ3548 (tlpA1) cloned into pSUP202pol3 
[16] 
[17] 
[18] 
[19] 
[20] 
This work 
This work 
This work 
[21] 
[2] 
This work 
[21] 
[2] 
This work 
New England Biolabs 
This work 
Pharmacia 
This work 
[18] 
T. Kaspar, ETH 
Zurich, unpublished 
This work 
This work 
This work 
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Fig. 3. Insulin reduction assay. TlpAsoi(P109H) (30 uM) (■), TlpAsoi (30 uM) (•) or E. coli thioredoxin (Trx, 1 uM) (♦) was incubated with 
0.1 M potassium phosphate buffer, pH 7.0, containing 2 mM EDTA and 1 mM DTT for 45 min at 25°C. Buffer with DTT alone served as 
control for the uncatalyzed reduction of insulin by DTT (A) . The reactions were started by addition of bovine pancreatic insulin (final concen-
tration: 0.13 mM) and precipitation of the reduced, free insulin chains was followed by the increase in optical density at 650 nm (OD650). Data 
were collected every 10 s; only some of the data are indicated by symbols. 
i? (IT — E ocr 
RT 
nF 
Cln/C, (5) 
After fitting the normalized fluorescence data by non-linear 
regression according to Eq. 4, equilibrium constants of 0.027 
M and 4.35 M were determined for the TlpAsoi(P109H)/glu-
tathione and TlpAsoi/glutathione systems, respectively. 
Although the latter value is about two times higher than the 
previously determined one [3], this does not greatly affect the 
calculation of the redox potential of the wild-type protein (see 
below). Using the Nernst equation (Eq. 5) and a value of 
—0.240 V [29] for the glutathione standard redox potential 
(£'OG). w e determined standard redox potentials (E'0T) of 
-0.193 V for TlpAsoi(P109H) and -0.259 V for TlpAsol. 
The latter value is in good agreement with that determined 
previously [3]. (A different value for E'0Q had been used in the 
previous work. For a better comparison, the previous data for 
TlpASoi were recalculated, resulting in a £'OT value of —0.248 
V.) Thus, the P109H exchange in TlpAsoi caused an increase 
in the redox potential by 66 mV. 
The disulfide reductase activity of TlpAsoi(P109H) was then 
compared to that of TlpAso] with the insulin reduction assay 
[24]. The three disulfide bridges of insulin are reduced by a 
slight excess of dithiothreitol in this assay, and the aggrega-
tion of reduced insulin is recorded by the increase of the 
optical density at 650 nm. As shown in Fig. 3, catalytic 
amounts of TlpAsoi(P109H) (1/13 at the disulfide level com-
pared to insulin) reduced insulin with an approximately 2.5-
fold higher maximal rate (AOD6so min
- 1) than the wild-type 
protein, which was accompanied by a twofold earlier onset of 
aggregation (see table below the graph in Fig. 3). In view of 
the more positive redox potential of TlpAsoi(P109H), this in-
crease in insulin reduction activity was unexpected. However, 
a possible explanation might be that recycling of the catalyti-
cally active, reduced form of TlpAsoi by DTT is the rate-limit-
ing step in the catalytic cycle. In this case, reduction of the 
stronger oxidant TlpAsoi(P109H) should indeed be faster than 
the reduction of the wild-type protein. 
To test this hypothesis, the reduction of TlpAsoi(P109H) 
and TlpAsoi by a 100-fold and 1000-fold molar excess of 
DTT, respectively, was measured in a stopped-flow experi-
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Fig. 4. Kinetics of the reduction of TlpAsaiCPlCWH) and TlpAsoi by 
DTT. Proteins (1 uM) were reduced under pseudo first-order condi-
tions using a 1000-fold molar excess of DTT for the wild-type 
TlpArf (•) and a 100-fold molar excess for TlpAsoi(P109H) (■). 
The reaction was followed by the increase in tryptophan fluores-
cence in a SX-17MV Stopped-Flow Reaction Analyser (emission 
cut-off filter of <320 nm). 
ment using the increase in tryptophan fluorescence (Fig. 4). 
The pseudo first-order rate constants (Kar>p) were determined 
to be 0.0211 s-1 and 0.126 s"1 for TlpAsoi and 
TlpAsoi(P109H), respectively. Second-order rates (K2-Kapv 
[DTT]"1) of 21 M - 1 s - 1 and 1181 M - 1 s - 1 , respectively, 
were calculated from these values. Thus, the increased activity 
of TlpAsoi(P109H) in insulin reduction is obviously due to an 
about 56 times faster recycling of the reduced catalyst by 
DTT. 
These data clearly showed that a Pro109-to-His exchange in 
TlpAsoi causes a significant change of the redox properties of 
this protein. It was therefore of interest to test whether this 
change had an effect on the in vivo functions of the protein. 
To prevent undesirable recombination events between the 
chromosomal tlpA gene and mutated tlpA genes that were 
to be introduced into the cells, we constructed a defined B. 
japonicum tip A deletion mutant, BJ3556, in which 545 nucleo-
tides (81.8%) of the chromosomal tip A gene were substituted 
by the kanamycin resistance cassette from plasmid pUC4-
KIXX. The phenotype of this mutant was similar to that of 
the B. japonicum COX64 mutant carrying a Tn5 insertion in 
tip A [1]. The plasmids containing either tip A or tip PI 09 H 
were then mobilized into strain BJ3556 (AtlpA) and integrated 
via homologous recombination upstream of the tip A deletion 
in the chromosome. The resulting strains were grown aerobi-
cally in PSY medium and assayed for cytochrome c oxidase 
activity in the membrane fractions. B. japonicum 1 Wspc4 (wild 
type) and BJ3556 (AtlpA) served as positive and negative con-
trols, respectively. No significant difference was observed be-
tween the activities of wild-type, BJ3583 (tlpP109H+) and 
BJ3582 (tlpA+) cells (0.786, 0.770 and 0.827 umol cyt c (mg 
protein) -1 min - 1 , respectively). Almost no activity was de-
tected in strain BJ3556 (AtlpA) (0.003 umol cyt c (mg 
protein) -1 min - 1). 
The same strains were used to infect soybean seedlings. 
Plants infected with BJ3582 (tlpA+) developed root nodules 
253 
that were similar in size and number to those of plants in-
fected with wild-type cells. They were of red colour inside 
(presence of leghemoglobin) and showed nitrogenase activities 
similar to those of nodules harbouring bacteroids of BJ3583 
(tlpP109H+) (265 and 268 umol ethylene h - 1 (mg nodule dry 
weight)-1 were produced). For comparison, nodules contain-
ing wild-type cells produced 184, those containing BJ3556 
(AtlpA) only 4 umol ethylene h - 1 (mg nodule dry weight)-1. 
4. Discussion 
A considerable change in the redox potential of TlpA (66 
mV more positive) did not cause an alteration of the in vivo 
functions of the protein. By contrast, a P34H variant of E. 
coli thioredoxin, possessing a redox potential that was only 35 
mV higher than that of the wild-type protein [13], was able to 
restore viability of a pdil deletion mutant of Saccharomyces 
cerevisiae (lacking protein disulfide isomerase), whereas mu-
tant cells containing the wild-type thioredoxin gene (trx) did 
not grow [30]. In this heterologous system, alteration of the 
redox potential enabled the variant thioredoxin to replace 
PDI in vivo. However, the phenotype of a trxP34H mutation 
within E. coli has not been reported as far as we know. 
An exchange of the amino acid residues between the two 
active-site cysteines of DsbA from E. coli also created variant 
proteins with different redox potentials. The strains carrying 
the different dsbA mutations were tested for their ability to 
overcome millimolar concentrations of DTT in the growth 
media. Although most of the mutants were more sensitive 
to DTT than the wild-type, the ranking of their sensitivity 
did not exactly reflect the ranking of their equilibrium redox 
potential [15]. 
How important are the intrinsic redox potentials of thiol: 
disulfide oxidoreductases for their function in vivo? In the 
most simple case, a thiol:disulfide oxidoreductase (E) is only 
catalyzing the transfer of electrons from a reductant (R) to an 
oxidant (O): 
R^E-^O 
A change of the redox potential of the enzyme, for instance by 
a point mutation, would mean that the rate constants of its 
oxidation and reduction change in opposite directions. How-
ever, the overall rate of electron transport and thus the in vivo 
function of the enzyme would not be affected by the altered 
redox potential, as long as the rate-limiting reaction (forma-
tion of oxidized or reduced enzyme) occurs at about the same 
rate as in the wild-type protein. This appears to be the case 
for variants of TlpA and other periplasmic thiol:disulfide ox-
idoreductases such as DsbA [15]. 
The situation is completely different in the lumen of the ER 
of eukaryotic cells. In this compartment, the excess of GSH 
and GSSG is likely to dictate the fractions of the oxidized and 
reduced forms of PDI. The GSH/GSSG ratio in the ER was 
determined to be between 1:1 to 3:1 with an estimated GSH 
concentration of about 0.5 to 1 mM [31]. From these concen-
trations and the equilibrium constants between the thioredox-
in-like domains of PDI and glutathione (0.7 mM for the a 
domain and 1.9 mM for the a! domain; [32]) it follows that 
the concentrations of oxidized and reduced PDI domains in 
the ER are practically identical ( = 20-60% and 40-80% oxi-
dized molecules in case of the a and a! domains, respectively). 
254 R. Rossmann et al.lFEBS Letters 406 (1997) 249-254 
This suggests that both the oxidized and the reduced form of 
PDI , i.e. its oxidase and isomerase activity, are very important 
for the in vivo function of the enzyme and that the PDI0 X / 
PDI re(j ratio indeed reflects the need for catalysis of formation 
of native disulfide bonds and reduction of nonnative disulfides 
in folding proteins: 
2 GSH + PDI0 X 
~ 5 0 % 
dithiol oxi-
dase activity 
GSSG + PDI r e d 
~ 5 0 % 
disulfide iso-
merase activity 
This would explain why the strong reductant thioredoxin is 
not capable to complement P D I deficiency in yeast, whereas 
the thioredoxin variant P34H, which has a PDI-like redox 
potential, restores yeast viability [30]. The general conclusion 
would be that the intrinsic redox potential of enzymes which 
are in a permanent, stationary equilibrium with a higher redox 
system, such as PDI with glutathione or thioredoxin with 
N A D P + / N A D P H , are critical for their in vivo function, 
whereas the overall rate of electron transfer rather than the 
redox potential is important for bacterial periplasmic thiol: di-
sulfide oxidoreductases. To further assess the mode of TlpA 
action in the periplasm of B. japonicum it will primarily be 
necessary to identify its target protein(s) and a linked redox 
system. 
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